Skip to main content Skip to main menu
UF Health University of Florida

Todd M. Brusko Laboratory

Developing the Cure for Type 1 Diabetes

UF Immune Monitoring Core

THE URGENCY OF NOW

Our lab works on a disease that impacts the lives of those who live with it and their families every hour of every day.

Lab news

Human Atlas of Neonatal Development and Early…

Category: Feature

Human Atlas of Neonatal Development and Early Life-Immunity (HANDEL-I) The early life events that influence immune system development have…

HANDEL-I

Helmsley Grant to UFDI to Study Immune Repertoire…

Category: Feature

University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B…

DNA

Join Our Mission

Category: Feature

The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”

TIGIT

News In Brief

  1. ATG Preserves β-Cell Function in Clinical Trial
  2. What’s your GRS?
  3. Characterizing Autoreactive T-Cell Receptors in Type 1 Diabetes
All Posts

International Clinical Centers

Type 1 Diabetes TrialNet

The University of Florida (UF) is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Desmond Schatz, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Biomedical Sciences Building